Skip to Content

Raplixa Approval History

FDA Approved: Yes (First approved April 30, 2015)
Brand name: Raplixa
Generic name: fibrin sealant [human]
Company: The Medicines Company
Treatment for: Hemostasis

Raplixa (fibrin sealant [human]) is a spray-dried fibrin sealant used to help control bleeding during surgery.

Development History and FDA Approval Process for Raplixa

DateArticle
Apr 30, 2015Approval FDA Approves Raplixa (fibrin sealant [human]) to Control Bleeding During Surgery

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide